Anda di halaman 1dari 4

DAFTAR PUSTAKA

1. World Health Organization. WHO STEPS Stroke Manual: the WHO STEPwise approach
to stroke surveillance. Geneva: World Health Organization; 2006. p. 4-6.
2. Ropper AH, Brown RH. Cerebrovascular Diseases. Adams and Victor’s Principles of
Neurology. 8 ed. New York: McGraw-Hill; 2005.
3. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik
Indonesia (BPPK Depkes RI). Laporan Nasional Riset Kesehatan Dasar (Riskesdas).
Jakarta: Depkes RI; 2013. ix-99.
4. Sonya M. Korelasi kadar trigliserida serum terhadap keluaran fungsional pada penderita
stroke iskemik akut di RSUD dr. Abdul Aziz Singkawang. (skripsi). Pontianak: Fakultas
Kedokteran Universitas Tanjungpura; 2015.
5. Dodi N. Hubungan antara jumlah Trombosit dan Early Neurological Deterioration (end)
pada pasien stroke iskemik akut di RSUD dr. Abdul Aziz Singkawang. (skripsi).
Pontianak: Fakultas Kedokteran Universitas Tanjungpura; 2015.
6. Harsono. Kapita Selekta Neurologi: Edisi II. Yogjakarta: Gajah Mada University Press;
2009. h. 81-102.
7. Mansjoer A, Suprohaita, Wardhani WI, Setiowulan W. Kapita Selekta Kedokteran. Edisi
Ketiga. Jilid 2. Jakarta: Media Aesculapius FKUI; 2009. pp.17-8.
8. Junaidi I. Stroke, Waspadai Ancamannya. Yogyakarta: Andi Offset. 2011.
9. Sutedjo AY. Mengenal Penyakit Melalui Hasil Pemeriksaan Laboratorium. Yogyakarta:
Amara Books; 2009. pp. 28.
10. Widijatno A, Dahlan P, Asmedi A. Peranan Hematokrit Sebagai Nilai Prognosis Stroke
Infark Di RS Dr. Srdjito Yogyakarta; BNS Vol. 7. 2006.
11. Wei Sun, Amanda Peacock, Jane Becker, Barbara Philips-Bute, Daniel T. Laskowitz and
Michael L. James. Correlation of leukocytosis with early neurological deterioration
following supratentorial intracerebral hemorrhage. J Clin Neurosci. Aug 2012; 19(8):
1096-100.
12. Helleberg BH, Ellekjaer H, Rohweder G, and Indredavik B. Mechanisms, predictors and
clinical impact of early neurological deterioration: the protocol of the Trondheim early
neurological deterioration study. BMC Neurology. 2014;201(14): 1-9.
13. Wang Q, Chen C, Chen XY, Han JH, Soo Y, Leung TW, Mok V, Wong KS. Low-
Molecular-Weight Heparin and Early Neurologic Deterioration in Acute Stroke Caused
by Large Artery Occlusive Disease. Arch Neural. Nov 2012; 69(11): 1454-9.
14. Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities
in early neurological deterioration. Stroke. 2009;40: 443-50.
15. Bugnicourt JM, Roussel B, Garcia PY, Canaple S, Lamy C, Godefroy O. Aspirin non-
responder status and early neurological deterioration: A prospective study. Clinical
Neurology and Neurosurgery. 2011; 113: 196–201.
16. Gandasoebrata R., 2007. Penuntun Laboratorium Klinik.Cetakan 13. Jakarta:Dian
Rakyat, pp. 39-40.
17. Harsono. Buku Ajar Neurologi Klinis. Yogyakarta: Gadjah Mada University Press; 2011.
p. 35-49, 59-107.
18. Gofir A, Indera, Noor A, Utomo AB. Manajemen Stroke Evidence Based Medicine,
Yogyakarta : Pustaka Cendekia Press; 2011. h. 9-94.
19. Hidayat AW. Hubungan Antara Kadar Hematokrit dengan Derajat Keparahan Stroke
Iskemik Fase Akut pada Pasien di Unit Penyakit Saraf RSUD Dokter Moewardi.
(skripsi). Surakarta; Fakultas Kedokteran Universitas Sebelas Maret; 2013.
20. Netter FH, Craig JA, editors. Atlas of Neuroanatomy and Neurophysiology. USA: Icon
Custom Communications; 2002.
21. Snell, Richard S. Anatomi Klinik untuk Mahasiswa Kedokteran; alih bahasa Liliana
Sugiharto; Ed 6. EGC: Jakarta; 2013. h. 525-553.
22. Misbach J. Stroke Aspek Diagnosis, Patofisiologi, Manajemen. Jakarta: Balai Penerbit FKUI;
2011. p. 1-57
23. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al.
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare
Professionals From the American Heart Association/American Stroke Association. Stroke
2011; 42:517-84.
24. Sjahrir H. Stroke Iskemik. Medan: Yandira Agung. 2003.
25. Michael B, Wolf DH. Textbook of Stroke Medicine. New York: Cambridge University
Press; 2010. p. 1-38
26. Smith WS, Johnston SC, & Easton JD. Cerebrovascular Disease. In: Hauser, S.L., ed.
Harrison’s Neurology in Clinical Medicine. USA: McGraw-Hill, 2006. 233-239.
27. Brouns R, De Deyn PP. The complexity of neurobiological processes in acute ischemic
stroke. Clin Neurol Neurosurg. 2009;111:483–95.
28. González RG, Hirsch JA, Lev MH, Schaefer PW, Schwamm LH. Acute Ischemic Stroke,
Imaging and Intervention. 2nd ed. New York : Springer Heidelberg Dordrecht; 2011. p.1-
24.
29. PERDOSSI. Pedoman stroke. Jakarta: Perhimpunan Dokter Spesialis Saraf Indonesia
(PERDOSSI); 2011.
30. De Freitas GR, Christoph DDH, Bogousslavsky J. Topographic classification of ischemic
stroke, in Fisher M. (ed). Handbook of Clinical Neurology, Vol. 93 (3rd series). Elsevier
BV, 2009.
31. PERDOSSI. Pedoman penatalaksanaan stroke. Jakarta: Perhimpunan Dokter Spesialis
Saraf Indonesia (PERDOSSI); 2011.
32. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al.
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A
Guideline for Healthcare Professionals From the American Heart Association/American
Stroke Association. Stroke. 2013; 44: 870-947.

33. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology, fifth edition. Churchill living
stone. 2011.
34. Kim JT, Park MS, Chang J, Lee JS, Choi KH, Cho KH. Proximal arterial occlusion in
acute ischemic stroke with low NIHSS scores should not be considered as mild stroke.
Plos one. 2013; 8(8): 1-7.
35. Siegler JE, Martin SS. Early Neurological Deterioration (END) after stroke: the END
depends on the definition. Int J Stroke. 2011 Jun; 6(3): 211-2.
36. Young DK, Dongbeom S, Eun HK, Ki JL, Hye SL, Chung MN, et al. Long-term
mortality according to the characteristics of early neurological deterioration in ischemic
stroke patients. Yonsei Med J, 2014. 55(3): 669-75.
37. Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic
stroke: predictors, mechanisms and management. Postgrad Med J. 2008;84:412-7.
38. Lumbantobing SM. Neurologi Klinik : Pemeriksaan Fisik dan Mental. Jakarta: Balai
Penerbit FKUI; 2011. h. 7-10.
39. Titu M, Aminul H, Raihan RK, Zannatun N, Rabiul IR, Binoy KT, et al. The Glasgow
Coma Scale following acute stroke and in-hospital outcome: an observational study. J
Medicine. 2009; 10(1): 11-4.
40. Mansour OY, Megahed MM, Elghany EHS. Acute ischemic stroke prognostication,
comparison between Glasgow Coma Score, NIHS Scale and Full Outline of
UnResponsiveness Score in Intensive Care Unit. Alex J Med. 2014 (in press).
41. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics
and impact on outcome. Q J Med. 2006; 99: 625–33.
42. Dostovic Z, Ibrahimagic OC, Smajlovic D, Dostovic E. Stroke and disorders of
consciousness. Cardiovascular Psychiatry and Neurology. 2012; 10: 1-4.
43. Middleton PM. Practical use of the Glasgow Coma Scale; a comprehensive narrative
review of GCS methodology. Australasian Emergency Nursing Journal; 15(3): 170-83.
44. Jaya I. Hubungan Kadar Hematokrit Awal dengan Derajat Klinis DBD. (skripsi).
Surakarta: Fakultas Kedokteran Universitas Muhammadiyah; 2016.

45. Yildrim Cinar,Gamze Demir, Mustafa Pac, Ayse Bazak Cinar. Effect of hematocrit on
blood pressure via hyperviscosity. American Journal of Hematology.1999;12:739-743

46. Y Kiyohara, M Fujishima, T Ishitsuka, K Tamaki, S Sadoshima and T Omae. Effects of


hematocrit on brain metabolism in experimentally induced cerebral ischemia in
spontaneously hypertensive rats (SHR). Journal of Amerian Heart of
Association.1985;16(5):838.

47. Leonardo J, Tamariz J, Hunter Y, James S, Pankow, HsinChieh Y, et al. Blood viscosity
and hematocrit as risk factors for type 2 diabetes mellitus the Atherosclerosis Risk In
Communities (ARIC) study. American Journal of Epidemiology. 2008;168(10):115 3-
1160.

48. Mardjono, Mahar, Sidharta, Priguna. Mekanisme Gangguan Vaskular Susunan Saraf
dalam Neurologi Klinis Dasar. Jakarta : Dian Rakyat. 2008.hal 269-92.